- Resource
- BR1DGE
- Disease Burden
- Video
The Growing Global Burden of T1D – ATTD 2026
The video discusses the rising T1D burden: Adult-onset misclassification, familial risk, and autoimmune comorbidities impacting diagnosis and management.
Learning Objectives
- Recognize the growing burden of T1D
- Understand the risk of misclassification in adults with T1D
- Identify autoimmune comorbidities that are associated with T1D
Summary
At ATTD 2026, Dr Sanjoy Dutta, explores the growing burden of T1D, highlighting that adults account for a significant proportion of new diagnoses; approximately 40% are initially misclassified as T2D and treated unsuccessfully for years. While familial T1D risk is elevated, most cases of T1D arise in individuals with no known family history. Several autoimmune conditions, including celiac disease and Hashimoto's thyroiditis, are associated with T1D. Long-term, people with T1D face a higher risk of complications compared to the general population.
MAT-GLB-2601649 - 1.0 - 04/2026
The Importance of Preserving Residual Beta-Cell Function in T1D
Maintaining residual beta-cell function in T1D improves glycemic control, reduces complications, and impacts care and outcomes in people with T1D.
Supporting islet-autoantibody-positive individuals and their families
Appropriate strategies can help support people with early-stage T1D and their families and address anxiety during early T1D monitoring, ensuring optimal engagement and care.
Early T1D Screening Recommendations
Expert insights on recommendations for T1D screening, including proposed age ranges and opportunities for integration into existing public health touchpoints.